Jane Street Group LLC Has $1.99 Million Holdings in Haleon plc (NYSE:HLN)

Jane Street Group LLC cut its stake in Haleon plc (NYSE:HLN - Free Report) by 21.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 208,666 shares of the company's stock after selling 56,311 shares during the period. Jane Street Group LLC's holdings in Haleon were worth $1,991,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of Haleon by 3.7% during the 4th quarter. FMR LLC now owns 108,827,814 shares of the company's stock worth $1,038,217,000 after buying an additional 3,909,545 shares in the last quarter. Wellington Management Group LLP raised its holdings in Haleon by 67.5% during the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock worth $146,232,000 after purchasing an additional 6,175,835 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in Haleon by 0.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock worth $72,793,000 after purchasing an additional 58,444 shares during the period. JPMorgan Chase & Co. boosted its stake in Haleon by 18.3% during the 4th quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock valued at $57,382,000 after purchasing an additional 930,701 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Haleon by 27.7% during the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock valued at $51,636,000 after purchasing an additional 1,172,931 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Up 1.2%

Shares of HLN stock traded up $0.13 during trading on Tuesday, hitting $11.01. 22,805,179 shares of the company were exchanged, compared to its average volume of 8,089,059. The firm has a market capitalization of $49.63 billion, a price-to-earnings ratio of 32.38, a P/E/G ratio of 2.82 and a beta of 0.24. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The business's 50-day simple moving average is $10.23 and its 200 day simple moving average is $9.87. Haleon plc has a twelve month low of $8.25 and a twelve month high of $11.05.

Haleon (NYSE:HLN - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The company also recently announced a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be given a $0.1166 dividend. This is a boost from Haleon's previous -- dividend of $0.05. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio (DPR) is 58.97%.

Analyst Upgrades and Downgrades

HLN has been the subject of several research reports. Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research report on Friday, May 9th. Barclays reaffirmed an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. HSBC restated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Five research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $11.25.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.